Article
The influence of genetic constitution on migraine drug responses.
Cephalalgia : an international journal of headache - 1 Jun 2016
Christensen Anne Francke, Esserlind Ann-Louise, Werge Thomas, Stefánsson Hreinn, Stefánsson Kári, Olesen Jes
Abstract excerpt
OBJECTIVE: Specific acute treatments of migraine are 5HT1B/D receptor agonists; triptans and ergotamine, but only two-thirds of patients respond well without side effects. No migraine-prophylactic drugs are specific to migraine. Prophylactic drugs are selected by time-consuming "trial and error." Personalized treatment is therefore much needed. The objective of this study was to test the effect of 12 single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
